




Searching News Database: LUNESTA
HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
HSMN NewsFeed - 13 Aug 2014
Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer
Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer
HSMN NewsFeed - 16 Apr 2014
Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
Dyax Corp. Announces Appointment of Todd Bazemore as Chief Commercial Officer
HSMN NewsFeed - 5 Sep 2012
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
Sunovion Pharmaceuticals Inc. Completes Acquisition of Elevation Pharmaceuticals, Inc.
HSMN NewsFeed - 9 Aug 2011
MAP Pharmaceuticals Appoints Frederick H. Graff Vice President, Commercial Operations
MAP Pharmaceuticals Appoints Frederick H. Graff Vice President, Commercial Operations
HSMN NewsFeed - 7 Jun 2011
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
XOMA Appoints Paul Rubin, M.D. as Vice President and Chief Medical Officer
HSMN NewsFeed - 4 Nov 2010
Euthymics Bioscience, Inc. Names Biotech Executive Timothy J. Barberich to Board of Directors
Euthymics Bioscience, Inc. Names Biotech Executive Timothy J. Barberich to Board of Directors
HSMN NewsFeed - 19 Feb 2010
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
HSMN NewsFeed - 17 Dec 2009
Sepracor Granted Patent Term Extension for LUNESTA(R) and Provides Update on LUNESTA Pediatric Studies
Sepracor Granted Patent Term Extension for LUNESTA(R) and Provides Update on LUNESTA Pediatric Studies
HSMN NewsFeed - 24 Sep 2008
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
New Data Show Efficacy and Safety of Eslicarbazepine Acetate in the Treatment of Epilepsy
HSMN NewsFeed - 3 Jun 2008
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada
HSMN NewsFeed - 1 May 2008
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
HSMN NewsFeed - 27 Jul 2007
Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing Authorization Application (MAA) for Europe
Sepracor Submits LUNIVIA(R) (LUNESTA(R) in U.S.) Marketing Authorization Application (MAA) for Europe
HSMN NewsFeed - 17 Jul 2007
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
William P. Kane Named Vice President, Commercial Operations for Keryx Biopharmaceuticals, Inc.
HSMN NewsFeed - 4 Dec 2006
LUNESTA(R) Perimenopause-Menopause Study Published in Journal of Obstetrics and Gynecology
LUNESTA(R) Perimenopause-Menopause Study Published in Journal of Obstetrics and Gynecology
HSMN NewsFeed - 12 Oct 2006
Newly Published Data Show Efficacy and Safety of LUNESTA(R) in Elderly Patients with Insomnia
Newly Published Data Show Efficacy and Safety of LUNESTA(R) in Elderly Patients with Insomnia
Additional items found! 16

Members Archive contains
16 additional stories matching:
LUNESTA
(Password required)
LUNESTA
(Password required)